3 Patents
- 0 cites
- US124339532025Compositions and Methods Related to Tumor Activated Antibodies Targeting EGFR and Effector Cell Antigens
JANUX THERAPEUTICS, Inc.
0 cites - US121617242024Compositions and Methods Related to Tumor Activated Antibodies Targeting EGFR and Effector Cell Antigens
JANUX THERAPEUTICS, Inc.
0 cites